Goedert HIV vaccine breakthrough: latest results
Today, the scientific community is buzzing about the Goedert HIV vaccine after a Phase II trial released promising efficacy data this week. The trial, led by virologist Dr. John Goedert at the University of Alberta, showed a measurable reduction in viral load among participants, reigniting hope for a long‑awaited preventive vaccine. Because the results were unveiled […]
